| LSCGX | RPEBX | LSCGX / RPEBX | |
| Total Expense Ratio | 1.95 | 1.21 | 161% |
| Annual Report Gross Expense Ratio | 2.13 | 1.21 | 176% |
| Fund Existence | 10 years | 11 years | - |
| Gain YTD | 1.886 | 2.832 | 67% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 135M | 163B | 0% |
| Annual Yield % from dividends | 0.00 | 0.57 | - |
| Returns for 1 year | 20.05 | 18.20 | 110% |
| Returns for 3 years | 77.82 | 45.46 | 171% |
| Returns for 5 years | 25.71 | 16.40 | 157% |
| Returns for 10 years | N/A | 120.89 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FWOMX | 19.45 | N/A | N/A |
| Fidelity Women's Leadership | |||
| CMRGX | 10.21 | N/A | N/A |
| Calamos Merger Arbitrage I | |||
| BRWCX | 25.88 | -0.06 | -0.23% |
| MFS Blended Research Growth Eq C | |||
| JFNSX | 77.45 | -0.23 | -0.30% |
| Janus Henderson Global Life Sciences S | |||
| GIEYX | 16.25 | -0.11 | -0.67% |
| GuideStone Funds International Eq Instl | |||